The latest news, stories and exciting findings from across the Oxford cancer research community
'Oxford LIVer cancer centre of Excellence' Launched
24 October 2024
To mark liver cancer awareness month, we are excited to announce the launch of the Oxford LIVer cancer centre of Excellence (OLivE) to improve outcomes for liver cancer patients.
Dr Bo Sun awarded Future Leaders Grant
15 October 2024
The three-year £225,000 grant from The Brain Tumour Charity will fund research into whether it's possible to use T-cells to track and detect gliomas.
UK cancer registry data is as accurate and timely as on-site trial data, new study shows
11 October 2024
Researchers from the Cancer Theme at Nuffield Department of Primary Care Health Sciences (NDPCHS) and Department of Oncology at the University of Oxford, report that cancer data collected by national cancer registries is comparable to the data gathered directly by researchers in clinical studies. This could make cancer research much easier and less expensive in the future.
OCION: In conversation with Alfred Zippelius
7 October 2024
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with Professor Alfred Zippelius to discuss his research.
Funding to create world's first ovarian cancer prevention vaccine
4 October 2024
Researchers from Oxford have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.
Pseudouridine landscape across the human transcriptome mapped
2 October 2024
The Song group at Ludwig Oxford in the Nuffield Department of Medicine have published a technique for mapping the pseudouridine landscape across the human transcriptome.
New study available on the Translational Data Platform
27 September 2024
Thanks to the Translational Data Platform (TDP) - launched in June - many Oxford scientists have already gained access to expertly curated data from past clinical trials. Data from a new study, METFORMIN, is now available.
Research in Focus for Childhood Cancer Awareness Month
18 September 2024
September is Childhood Cancer Awareness Month. We sat down with Dr Eleni Louka, Academic Clinical Lecturer, to learn more about her research into rare childhood blood cancers.
Researchers develop new tool to better predict AML outcomes in older patients
17 September 2024
In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.
CRUK funding success to take LynchVax from an OCION Pump Prime award towards a clinical trial
16 September 2024
Fewer than 12 months ago the ‘Oxford Cancer Immuno-Oncology Network’ (OCION) awarded £20,000 Pump Prime funding to a team led by Associate Professor David Church, who has now grown this pot over 27-times in funding from CRUK!
CRUK Oxford Development Fund - now open for applications!
16 September 2024
The CRUK Oxford Development Fund is now open for applications!
OxCODE travel award winner featured by Cancer Research UK
13 September 2024
Dr Zhe Huang talks about his work on investigating the proteomic profiles of prostate cancer, his OxCODE-funded trip to Boston and the story behind his early career
Oxford and NTU Singapore Study discovers new process for cells to repair DNA damage
11 September 2024
A team of international researchers at the University of Oxford (Oxford) and Nanyang Technological University, Singapore (NTU Singapore), has discovered a new process for repairing damaged DNA that is particularly relevant for patients undergoing colorectal cancer treatments.
OCION: In conversation with Ignacio Melero
11 September 2024
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with Professor Ignacio Melero to discuss his research.
Oxford receives funding to develop a cancer prevention vaccine for Lynch syndrome
10 September 2024
Cancer Research UK funds University of Oxford scientists to develop ‘LynchVax’, the UK’s first vaccine aiming to prevent cancer in people with Lynch syndrome who have a much higher risk of developing several types of cancer.
Senior Fellowship awarded to Beth Psaila
29 August 2024
Congratulations to Beth Psaila, who has been awarded a Senior Fellowship funded by Cancer Research UK in partnership with Rosetrees Trust.
CRUK funding will help develop new targets for ovarian cancer
21 August 2024
Irina Udalova has received funding from Cancer Research UK (CRUK) to study the diverse role of neutrophils in ovarian cancer.
Ground-breaking study reveals previously unknown genetic causes of colorectal cancer
7 August 2024
A pioneering study, led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the University of Manchester and the University of Leeds, has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC).
UK’s most ambitious melanoma research study created for patients, by patients
6 August 2024
Oxford Cancer Study Manager, Daniel McAleese, sat down with the NIHR Oxford Biomedical Research Centre to discuss the My Melanoma Trial.
Three hospital trusts participating in an Oxford-led study evaluating AI software for diagnosing prostate cancer in clinical settings
29 July 2024
Oxford University Hospitals (OUH) NHS Foundation Trust, North Bristol NHS Trust, and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust are evaluating a new Artificial Intelligence (AI) diagnostic system that could help improve prostate cancer diagnosis.